Every few months, the CDCN Executive Leadership Team selects a "Team Member of the Month" or "Cure Champion," who is helping to accelerate the CDCN's progress towards a cure. Check out our listing below:
October 2017: Kate Innelli was named "Team Member of the Month" for her support and leadership in engaging donors that help to enable high impact research to continue the fight against Castleman disease!
September 2017: Nathan Hersh was named "Team Member of the Month" for his continued work on launching our Biobank and on ACCELERATE. As an ACCELERATE research assistant, he ensures patient records get entered in a timely and accurate fashion!
August 2017: Jasira Ziglar and Shawnee Bernstein were named "Team Members of the Month" for their hard work on the ACCELERATE Registry. Over the last year, they have continuously gone above and beyond the call of duty to collect and review important patient data.
July 2017: Morgan Purcell was named "Team Member of the Month" for her dedication to spreading awareness of Castleman disease. Over the last two years, Morgan has been essential to getting the word out and keeping our social media audience engaged!
May 2017: Greta Moretto and Alisa McDonald were named "Team Members of the Month" for their innovative approach and dedication to raising awareness about Castleman disease!
April 2017: Jenna Kapsar was named "Team Member of the Month" for her hard work to engage with physicians around the world, track experts for referrals, and thank generous donors to the CDCN. Thanks!
February 2017: Sheila Pierson was named "Team Member of the Month" for her hard work to improve the ACCELERATE registry, help patients throughout the research process, and push forward an important proteomics study!
January 2017: Helen Partridge was named "Team Member of the Month" for her hard work to support CD patients and loved ones during their most difficult times while also managing dozens of other projects and tasks for the organization!
June 2016: Stefanie Soegaard was named "Team Member of the Month" for her hard work and dedication related to getting samples for research.
May 2016: Barclay Nihill was named Cure Champion for his incredible contributions to the Development division, particularly with regards to the Advisory Council to Cure Castleman disease
January 2016: Amy Liu's systematic literature review in The Lancet Haematology is a major contribution to understanding of iMCD. Amy is the first author and likely one of the only undergraduate first authors ever in that journal or the Lancet family of journals.
December 2015: Hayley Williamson provided all of the coordination and logistical support to establish a diagnostic criteria, which is going to help doctors to identify and diagnose patients more quickly--helping to save lives! The meeting included 21 representatives from all over the world, including Japan, New Zealand, France, and across the US.
October 2015: Dr. Dustin Shilling, PhD, who is our Senior Director of Research Execution/Operations, was selected after joining the CDCN team like a firestorm--pushing studies and projects forward while embodying the CDCN culture of patient impact with urgency.
September 2015: Alex Suarez, our Biobank co-leader and study naming genius, was selected for his hard work and for embodying all of the CDCN's values, which makes it fun to be a part of the team.
August 2015: Steph Serafino, our former Castleman Warrior Director, was selected for her work leading the Warrior program, which raised $74,000 in its first year.
July 2015: Dr. Chris Nabel, MD, PhD was chosen as the first "Cure Champion" based on his 2 years of dedication to the CDCN, continued scientific guidance and leadership, and incredible work to drive forward the HUNT/Pathogen Discovery study. Chris was later named to Forbes Magazine's 30 Under 30 Science list! http://www.forbes.com/30-under-30-2016/science/ Based on an organization of our size and 66M people 15-30 years old in the US, there is a 1 in 13,444,444 chance that the CDCN would have 30 Under 30 winners in back to back years! Chris said the honor was a testament to the CDCN and all that we've been able to accomplish.